Unlock instant, AI-driven research and patent intelligence for your innovation.

Analyte detection method

An analyte, a technology for detecting samples, applied in the field of analyte detection, which can solve problems such as changes

Pending Publication Date: 2020-06-16
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Any inhomogeneity will cause variation, and analytes must be able to efficiently settle and elute from the filter paper

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Analyte detection method
  • Analyte detection method
  • Analyte detection method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0179] Example 1: Identification of stable solvents for CMS and iso-CMS methods.

[0180] To identify alternative solvents, the standard curve and detection sensitivity of blood [ONDS] measurements, which were performed under CMS conditions, were examined as Figure 3A and 3B shown. Whole blood was diluted 10-fold into a stable solution containing one of acetonitrile, isopropanol, methanol, or ethanol (25% V / V) and water, each of which is less toxic than acetonitrile, i.e. requiring more High doses are required for them to exhibit toxic effects. They were then used to measure blood samples infused with a range of [ONDS]. Assays were performed as described above. All extraction solvents tested yielded the same results as the acetonitrile control sample ( Figure 7A ). Isopropanol was chosen for further testing and its use as a stable solvent for [ONDS] measurements in a clinical setting. Again, these tests and measurements were performed as described above. Studies have...

Embodiment 2

[0182] Example 2: Detection of blood markers with iso-CMS

[0183]In this example, blood markers of genetic diseases were accurately measured by the iso-CMS method described herein. Therefore, the study shows that this genetic disorder can be easily, quickly and non-invasively diagnosed using these methods.

[0184] Phenylketonuria (PKU) provides an example of a treatable IEM. PKU (OMIM261600) is an autosomal recessive IEM caused by a deficiency in the 452 amino acid enzyme (phenylalanine hydroxylase, PAH) encoded by the 171kB gene on chromosome 12q23. amino acid (Phe) metabolism. Accumulation of toxic Phe metabolites can lead to growth failure, microcephaly, seizures, developmental delay, and severe intellectual disability.

[0185] Screening and treatment. PKU is the first genetic disorder to receive an effective treatment, which involves limiting dietary intake of phenylalanine. Therefore, screening newborns for PKU is crucial. Typically, neonatal blood is obtained by...

Embodiment 3

[0192] Example 3: Biomarkers of Genetic Diseases Measured by iso-CMS

[0193] In this example, blood markers of genetic diseases were accurately measured by the iso-CMS method described herein. Therefore, the study shows that this genetic disorder can be easily, quickly and non-invasively diagnosed using these methods.

[0194] Maple syrup diabetes (MSUD, MIM#248600) is an autosomal recessive inborn error of metabolism (IEM). The normal activity of the branched-chain alpha-ketoacid dehydrogenase (BCKAD) complex is disrupted by mutations, which interfere with the catabolism of branched-chain amino acids (BCAAs) including valine, leucine, and isoleucine. BCAAs were elevated in plasma and urine in diseased subjects. MSUD is characterized by neurological and developmental delays, encephalopathy, feeding problems and a maple syrup smell in the urine. If left untreated, MSUD can lead to metabolic decompensation, irreversible neurological damage and death. A recent analysis of MS...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Methods, kits and systems described herein provide collecting, preparing, processing and / or analyzing a clinical sample, such as a blood. The methods, kits and systems may use a biocompatible solutioncomprising water and a stabilizing solvent, such as isopropanol, for accurate testing of the presence and / or amount of drug, nutrient, or metabolite.

Description

[0001] cross reference [0002] This application claims the benefit of U.S. Provisional Application No. 62 / 580,277, filed November 1, 2017, and U.S. Provisional Application No. 62 / 615,576, filed January 10, 2018, each of which is hereby incorporated by reference. [0003] Statement of Government Funding [0004] This invention was made with Government support under Contract 5R01HD070795 awarded by the National Institutes of Health. The government has certain rights in this invention. [0005] field of invention [0006] The present invention relates to the diagnostic measurement of drug or metabolite levels. [0007] Background of the invention [0008] For many fields of medicine, the results obtained from diagnostic tests are important for proper diagnosis and treatment. However, existing systems and methods for clinical testing suffer from a number of disadvantages. Currently, existing methods cannot accurately test small amounts of blood. Additionally, many current ur...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N1/40G01N33/48G01N33/49
CPCG01N33/49G01N33/50B01L3/5023B01L2300/0636B01L2300/126A61B5/150022A61B5/151A61B10/0051A61B10/0058A61B10/0064A61B10/007A61B2010/0067A61B2010/0077A61B2503/045G01N33/6893G01N33/94G01N33/9486
Inventor G·帕尔兹M·吴
Owner THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV